YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

The Prediction of Overall Survival With The Use of The Sarculator in Operated Soft Tissue Sarcoma of The Extremities: Monocentre Experience

dc.authorscopusid 57215653678
dc.authorscopusid 57190280701
dc.contributor.author Sezgin, Y.
dc.contributor.author Karhan, O.
dc.date.accessioned 2025-05-10T16:54:55Z
dc.date.available 2025-05-10T16:54:55Z
dc.date.issued 2023
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Sezgin Y., Yüzüncü Yıl University, Faculty of Medicine, Clinic of Mecical Oncology, Van, Turkey; Karhan O., Gaziantep private Liv hospital medical oncology department, Gaziantep, Turkey en_US
dc.description.abstract Soft tissue sarcomas are rare malignancies with poor prognosis and more than 100 histologic subtypes. Due to their poor prognosis, accurate prognosis cannot be made by the staging system alone. Therefore, normograms have been developed for sarcoma patients. In this study, it was aimed to investigate the real-life data of prognosis prediction of sarculator normogram. Retrospective observational research was used in our study and the records of 146 patients were reviewed. The study included 50 patients who met the study criteria. The prognostic factors in sarcoma patients were analyzed in the study. Tumor size, tumor grade, age, and histologic subtype of the tumor were examined. In addition, all patients were graded using the sarcoma normogram and divided into percentile groups. The study's patient population had a median age of 47 years. 37 months was the median overall survival time. Patients with tumor grade 3 showed a statistically lower overall survival than those with grade 1 according to univariate analysis. Among patients divided into three groups according to Sarculator scoring, the high-risk group had a statistically significant difference of 23 months, the intermediate-risk group of 39 months, and the good-risk group of 93 months. Increased tumor size and grade were statistically significantly associated with poor survival, which was consistent with the literature. Statistically significant 5-10 year survival data were obtained in patients divided into 3 groups and compared with sarcolator. Thus, the accuracy of the Sarcolator was confirmed with real-world data. © 2023, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2023.31644
dc.identifier.endpage 809 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 4 en_US
dc.identifier.scopus 2-s2.0-85174469449
dc.identifier.scopusquality Q4
dc.identifier.startpage 804 en_US
dc.identifier.trdizinid 1263562
dc.identifier.uri https://doi.org/10.5505/ejm.2023.31644
dc.identifier.uri https://hdl.handle.net/20.500.14720/3306
dc.identifier.volume 28 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Nomograms en_US
dc.subject Ofttissuesarcoma en_US
dc.subject Prognosis en_US
dc.title The Prediction of Overall Survival With The Use of The Sarculator in Operated Soft Tissue Sarcoma of The Extremities: Monocentre Experience en_US
dc.type Article en_US

Files